Abeona Therapeutics (ABEO) Current Taxes (2025 - 2026)

Abeona Therapeutics' (ABEO) quarterly Current Taxes came in at $2000.0 in Q1 2026, down 98.44% quarter-over-quarter from $128000.0 in Q4 2025.

Abeona Therapeutics (ABEO) Current Taxes (2025 - 2026) Analysis & Trends

Abeona Therapeutics' Current Taxes history runs 2 years deep, the most recent figure standing at $2000.0 for Q1 2026.

On a quarterly basis, Current Taxes changed N/A year-over-year to $2000.0 in Q1 2026; TTM through Mar 2026 was $2000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $128000.0, changed N/A from the prior year.
Current Taxes eased to $2000.0 in Q1 2026 per ABEO's latest filing, from $128000.0 in the prior quarter.
Across five years, Current Taxes topped out at $15.5 million in Q2 2025 and bottomed at $2000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	63.52 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	49.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Abeona Therapeutics	107.85 Mn	-60.42 Mn	6.02 Mn	2,000.00

Download Data